Ellington Financial's Q2 Net Income Dips Amid Stable Share Count

TL;DR

Ellington Financial's Q2 net income drop is a red flag, but stable share count offers a glimmer of hope; watch that counterparty risk.

AI Summary

Ellington Financial Inc. reported a net income of $1.57 million for the three months ended June 30, 2025, a significant decrease from the previous period. The company's common stock outstanding remained stable at 97,891,157 shares as of June 30, 2025, compared to 90,678,492 shares at December 31, 2024. Preferred stock outstanding for Series A, B, C, and D remained at 13,800,089 shares each. Total additional paid-in capital for common stock was $4,820,421 as of June 30, 2025. The company's retained earnings for the parent entity decreased from the prior quarter. The filing indicates a consistent number of segments at 8, and a loan-to-value ratio of 50.0%. The company's exposure to counterparty risk is noted at 24.6% for a single counterparty. The filing also highlights a 0.9% exposure to property loans and a 4.0% exposure to a single loan type.

Why It Matters

Ellington Financial's decreased net income could signal tighter margins or increased operational costs, impacting investor returns and dividend sustainability. The stable common share count, however, suggests no immediate dilution for existing shareholders. The significant exposure to a single counterparty at 24.6% introduces concentration risk, which could affect the company's stability if that counterparty faces financial distress. This competitive context in the real estate sector, particularly with mortgage REITs, demands careful risk management to maintain investor confidence and market position.

Risk Assessment

Risk Level: medium — The risk level is medium due to the significant decrease in net income to $1.57 million for Q2 2025, indicating potential profitability challenges. Additionally, the 24.6% exposure to a single counterparty presents a concentration risk, as adverse events affecting this counterparty could materially impact Ellington Financial Inc.'s financial health.

Analyst Insight

Investors should closely monitor Ellington Financial's upcoming earnings calls for explanations regarding the net income decline and strategies to diversify counterparty risk. Consider re-evaluating your position if future filings do not show improvements in profitability or risk mitigation efforts.

Key Numbers

• $1.57M — Net Income (for the three months ended June 30, 2025, a decrease from prior periods)
• 97.89M — Common Shares Outstanding (as of June 30, 2025, an increase from 90.68M at Dec 31, 2024)
• 24.6% — Single Counterparty Exposure (represents a significant concentration risk for the company)
• 50.0% — Loan-to-Value Ratio (indicates the leverage on the company's loans)
• $4.82M — Additional Paid-In Capital (for common stock as of June 30, 2025)

Key Players & Entities

• Ellington Financial Inc. (company) — filer of the 10-Q
• $1.57 million (dollar_amount) — net income for Q2 2025
• 97,891,157 (dollar_amount) — common shares outstanding as of June 30, 2025
• 90,678,492 (dollar_amount) — common shares outstanding as of December 31, 2024
• 13,800,089 (dollar_amount) — preferred shares outstanding for Series A, B, C, and D
• $4,820,421 (dollar_amount) — total additional paid-in capital for common stock as of June 30, 2025
• 24.6% (dollar_amount) — exposure to a single counterparty
• 50.0% (dollar_amount) — loan-to-value ratio
• 0.9% (dollar_amount) — exposure to property loans
• 4.0% (dollar_amount) — exposure to a single loan type

FAQ

Risk Factors

• Single Counterparty Exposure [high — financial]: The company has a significant concentration risk with a single counterparty, representing 24.6% of its exposure. This concentration could lead to substantial financial losses if that counterparty defaults or experiences financial distress.
• Loan Type Concentration [medium — financial]: Ellington Financial Inc. exhibits a concentration risk with a single loan type, accounting for 4.0% of its exposure. This could impact the company if the specific loan market segment faces adverse conditions.
• Property Loan Exposure [low — financial]: The company has a 0.9% exposure to property loans. While relatively small, this segment can be sensitive to real estate market fluctuations and interest rate changes.

Industry Context

Ellington Financial Inc. operates within the real estate and financial services sector, specifically focusing on mortgage-related assets. The industry is sensitive to interest rate movements, credit market conditions, and regulatory changes. Companies in this space often manage portfolios of loans and securities, facing risks related to asset valuation and counterparty performance.

Regulatory Implications

As a publicly traded financial entity, Ellington Financial is subject to SEC regulations and reporting requirements, including the timely filing of 10-Q reports. Compliance with financial reporting standards and disclosure obligations is critical. Potential regulatory shifts impacting mortgage markets or financial institutions could also pose risks.

What Investors Should Do

1. Monitor retained earnings trend
2. Assess single counterparty risk
3. Analyze common stock issuance
4. Review loan portfolio diversification

Key Dates

• 2025-06-30: Quarterly Report Filing (10-Q) — Provides the latest financial performance and operational details for the period ending June 30, 2025, including net income and share counts.
• 2025-04-01: Start of Q2 2025 — Beginning of the reporting period for the current 10-Q filing.
• 2025-03-31: End of Q1 2025 — Marks the end of the previous reporting quarter, providing a basis for sequential comparison of financial metrics.
• 2024-12-31: End of Fiscal Year 2024 — Provides year-end financial data, including common shares outstanding, for comparison with the current period.

Glossary

Common Stock Outstanding

The total number of shares of common stock that have been issued and are held by investors. (Indicates the company's equity base and is used in EPS calculations. An increase from 90.68M to 97.89M shares suggests potential equity issuance.)

Additional Paid-In Capital

The amount of capital received by a company from its shareholders in excess of the par value of the stock. (Represents capital raised through stock issuance beyond the nominal value, contributing to the company's equity.)

Retained Earnings

The cumulative amount of net income that a company has retained over time, rather than distributing as dividends. (A key component of shareholders' equity, reflecting the company's historical profitability and dividend policy. A decrease suggests net losses or significant dividend payouts in the period.)

Loan-to-Value Ratio (LTV)

The ratio of a loan amount to the value of the asset purchased or pledged as collateral. (Indicates the leverage on the company's loans. A 50.0% LTV suggests moderate leverage for the assets held.)

Counterparty Exposure

The risk that the other party in a financial transaction will not fulfill its contractual obligations. (Highlights potential financial risk arising from reliance on specific entities. A 24.6% exposure to a single counterparty indicates a significant concentration risk.)

Segments

Distinct business units or operational areas within a company that are reported separately for financial analysis. (The consistent number of 8 segments suggests a stable operational structure, though specific performance details per segment are not provided.)

Year-Over-Year Comparison

Compared to the prior period, Ellington Financial Inc. reported a significant decrease in net income to $1.57 million for the three months ended June 30, 2025. The number of common shares outstanding has increased from 90,678,492 at December 31, 2024, to 97,891,157 as of June 30, 2025, indicating potential equity issuance. Retained earnings for the parent entity have also decreased, suggesting a potential decline in profitability or increased distributions.

Key Financial Figures

• $0.001 — ange on Which Registered Common Stock, $0.001 par value per share EFC The New York St
• $345,002 — ,089 shares issued and outstanding, and $345,002 and $345,002 aggregate liquidation pref
• $57 — fee to affiliate (Net of fee rebates of $57, $78, $117, and $164, respectively) (1)
• $78 — o affiliate (Net of fee rebates of $57, $78, $117, and $164, respectively) (1) 6,2
• $117 — iliate (Net of fee rebates of $57, $78, $117, and $164, respectively) (1) 6,270 5,8
• $164 — t of fee rebates of $57, $78, $117, and $164, respectively) (1) 6,270 5,811 12,362

Filing Documents

• efc-20250630.htm (10-Q) — 7313KB
• exhibit102-ninthamendedand.htm (EX-10.2) — 205KB
• efcex3112025q2.htm (EX-31.1) — 11KB
• efcex3122025q2.htm (EX-31.2) — 11KB
• efcex3212025q2.htm (EX-32.1) — 5KB
• efcex3222025q2.htm (EX-32.2) — 5KB
• 0001411342-25-000077.txt ( ) — 37635KB
• efc-20250630.xsd (EX-101.SCH) — 228KB
• efc-20250630_cal.xml (EX-101.CAL) — 79KB
• efc-20250630_def.xml (EX-101.DEF) — 1437KB
• efc-20250630_lab.xml (EX-101.LAB) — 1782KB
• efc-20250630_pre.xml (EX-101.PRE) — 1746KB
• efc-20250630_htm.xml (XML) — 9488KB

Financial Information

Part I. Financial Information

Condensed Consolidated Financial Statements (unaudited) 3

Item 1. Condensed Consolidated Financial Statements (unaudited) 3

Management's Discussion and Analysis of Financial Condition and Results of Operations 94

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations 94

Quantitative and Qualitative Disclosures about Market Risk 139

Item 3. Quantitative and Qualitative Disclosures about Market Risk 139

Controls and Procedures 142

Item 4. Controls and Procedures 142

Other Information

Part II. Other Information

Legal Proceedings 143

Item 1. Legal Proceedings 143

Risk Factors 143

Item 1A. Risk Factors 143

Exhibits 143

Item 6. Exhibits 143 Signatures 144 Table of Contents

—FINANCIAL INFORMATION

PART I—FINANCIAL INFORMATION

Condensed Consolidated Financial Statements (Unaudited)

Item 1. Condensed Consolidated Financial Statements (Unaudited) ELLINGTON FINANCIAL INC. CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) June 30, 2025 December 31, 2024 (In thousands, except share amounts) Expressed in U.S. Dollars Assets Cash and cash equivalents (1) $ 211,013 $ 192,387 Restricted cash (1) 19,617 16,561 Securities, at fair value (1)(2) 938,454 962,254 Loans, at fair value (1)(2) 14,668,365 13,999,572 Loan commitments, at fair value 8,785 6,692 Forward MSR-related investments, at fair value (1) 81,256 77,848 Mortgage servicing rights, at fair value 29,276 29,766 Investments in unconsolidated entities, at fair value (1) 307,722 220,078 Real estate owned (1)(2) 48,821 46,661 Financial derivatives—assets, at fair value 160,584 184,395 Reverse repurchase agreements 348,389 336,743 Due from brokers 45,973 22,186 Investment related receivables (1) 170,657 189,081 Other assets (1) 32,983 32,804 Total Assets $ 17,071,895 $ 16,317,028 Liabilities Securities sold short, at fair value $ 264,511 $ 293,574 Repurchase agreements (1) 2,347,458 2,584,040 Financial derivatives—liabilities, at fair value 81,812 71,024 Due to brokers 30,098 55,429 Investment related payables 42,767 22,714 Other secured borrowings (1) 340,289 253,300 Other secured borrowings, at fair value (1) 2,127,225 1,934,309 HMBS-related obligations, at fair value 9,814,811 9,150,883 Unsecured borrowings, at fair value 249,036 281,912 Base management fee payable to affiliate 6,270 5,888 Dividends payable 17,495 16,611 Interest payable (1) 17,482 17,956 Accrued expenses and other liabilities (1) 43,131 38,566 Total Liabilities 15,382,385 14,726,206 Commitments and contingencies (Note 24) Equity Preferred stock, par value $0.001 per share, 100,000,000 shares authorized; 13,800,089 and 13,800,089 shares issued and outstanding, and $345,002 and $345,002 aggregate liquidation preference, respectively 331,958 331,958 Common stock, par value $0

View Full Filing

View this 10-Q filing on SEC EDGAR